A new study published in the journal Science Signaling has found that an immune system protein plays a central role in the ...

The intricate link between endocrine disorders and cancer development has drawn significant interest, revealing how ...

Examination of transdermal berberine delivery, GLP-1 pathway terminology in supplement marketing, and consumer evaluation ...

A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...

The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

The Cambridge, Massachusetts-based company – known as FogPharma until a rebrand in 2024 – needs cash for pivotal trials of ...

Scientists have uncovered a connection between oral health and brain health. New research suggests that a common ...

Scientists have uncovered how a vitamin A metabolite can suppress anti-cancer immunity. Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have uncovered new ...

The phase 3 KANDLELIT-007 trial (NCT07190248) evaluating the KRAS G12C inhibitor calderasib (MK-1084) plus subcutaneous pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex; SC pembrolizumab) ...

A study led by researchers at Moffitt Cancer Center found that normal cells surrounding a tumor, known as cancer-associated ...

The term best semaglutide for weight loss in 2026 reflects growing consumer interest in medically supervised GLP-1 weight loss programs. As demand for effective and regulated weight management ...

This comprehensive review synthesizes a decade of human and animal research to explain how the gut and brain communicate ...